Freeman Brian M, Tingen Joseph S, Cull David L, Carsten Christopher G
Greenville Health System, Greenville, SC.
J Vasc Surg Cases Innov Tech. 2019 Jul 9;5(3):350-355. doi: 10.1016/j.jvscit.2019.03.015. eCollection 2019 Sep.
The "inside-out" technique eliminates the need for subclavian or femoral catheter placement by placing a supraclavicular catheter via a percutaneous femoral vein access. Few reports of its use in vascular surgery exist. The purpose of this article is to describe our version of the technique and report results. Between 2016 and 2017, the inside-out technique was performed on eight patients. All patients had more than four prior access sites and bilateral internal jugular vein occlusion. The technical success rates were 100% with no periprocedural complications and success in achieving dialysis access. One patient required catheter replacement within 48 hours, one catheter was used as a bridge to Hemodialysis Reliable Outflow (Hemosphere, a Cryolife Inc Company, Eden Prairie, Minn) graft placement, and one patient died of sepsis unrelated to their catheter. Our data show the inside-out technique to be safe and effective, removes the need for subclavian or femoral catheter placement, and should be a component of treatment algorithms for complex dialysis patients, which is consistent with National Kidney Foundation's Kidney Disease Outcomes Quality Initiative recommendations.
“由内向外”技术通过经皮股静脉穿刺置入锁骨上导管,从而无需放置锁骨下或股静脉导管。关于其在血管外科手术中的应用报道较少。本文旨在描述我们改进后的该技术并报告结果。2016年至2017年期间,对8例患者实施了“由内向外”技术。所有患者既往均有超过4个穿刺部位且双侧颈内静脉闭塞。技术成功率为100%,围手术期无并发症,且成功建立了透析通路。1例患者在48小时内需要更换导管,1根导管用作通向血液透析可靠流出道(Hemosphere,Cryolife公司,明尼苏达州伊甸草原)移植物置入的桥梁,1例患者死于与导管无关的败血症。我们的数据表明,“由内向外”技术安全有效,无需放置锁骨下或股静脉导管,应成为复杂透析患者治疗方案的一部分,这与美国国家肾脏基金会的《肾脏病预后质量倡议》建议一致。